Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 116 clinical trials
featured
ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Adult Subjects with Recurrent Clostridioides difficile Infection (RCDI)

ECOSPOR IV is a Phase 3, multicenter, Open Label study to evaluate the safety and tolerability of SER-109 in adult subjects with recurrent CDI.

clostridium difficile
  • 41 views
  • 21 Dec, 2020
  • 77 locations
featured
ECOSPOR III: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults

SER-109 versus placebo to reduce recurrence of Clostridium difficile infection (CDI) in adults who have received antibacterial drug treatment for recurrent CDI (RCDI), based on the proportion of

antibiotic therapy
fidaxomicin
clostridium difficile
antibiotics
vancomycin
  • 1107 views
  • 21 Dec, 2020
  • 72 locations
featured
Clostridium Difficile (C. Diff)

Clostridium Difficile (C. Diff)

  • 526 views
  • 25 Mar, 2021
  • 1 location
featured
Clostridium difficile infection (C-Diff)

Clostridium difficile infection (C-Diff)

  • 38 views
  • 08 Nov, 2020
  • 1 location
featured
C diffense - Clostridium Difficile Vaccine Trial

C diffense - Clostridium Difficile Vaccine Trial

  • 294 views
  • 08 Nov, 2020
  • 1 location
featured
Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

  • 228 views
  • 25 Mar, 2021
  • 1 location
featured
A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older

A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older

  • 1672 views
  • 25 Mar, 2021
  • 1 location
featured
Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?

Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?

  • 260 views
  • 23 Nov, 2020
  • 1 location
featured
Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

  • 182 views
  • 25 Mar, 2021
  • 1 location
Screening to Prophylax Against Clostridium Difficile Infection -

The goal of this study is to evaluate whether using vancomycin orally can prevent CDI in patients who are colonized with C. diff who are admitted to the hospital and need antibiotics for another infection.

cephalosporin
antibiotic therapy
vancomycin
clostridium difficile
antibiotics
  • 2 views
  • 01 Mar, 2021
  • 1 location